Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (631-640 of 676) with videos related to

Pageof 68
Sort By:
Lancet (London, England)|April 17, 2017
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 studyBrian G Feagan, William J Sandborn, Geert D'Haens, et al.
Gastroenterology|July 15, 2019
Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in MiceRocío López-Posadas, Petra Fastancz, Luz Del Carmen Martínez-Sánchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer AgentsPauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Nature Communications|March 12, 2016
Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitisMoritz Leppkes, Christian Maueröder, Sebastian Hirth, et al.
Gastroenterology|June 19, 2021
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative ColitisMaximilian Baumgartner, Michaela Lang, Hunter Holley, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Phytotherapy Research : PTR|April 27, 2026
The Allium cepa Derived Compound Propyl Propane Thiosulfonate (PTSO) Improves Tumorigenesis Due to Its Immunomodulatory Effect: A Preclinical StudyMaría Jesús Rodríguez-Sojo, Laura Hidalgo-García, Jose Alberto Molina-Tijeras, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseDominik Roth, Miriam M Düll, Ludwig J Horst, et al.
Journal of Crohn'S & Colitis|September 25, 2023
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel DiseasesSimone Weber, Selina Sitte, Anna-Lena Voegele, et al.
Biochemical Pharmacology|June 26, 2025
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposingJanine Haupt, Oliver Keminer, Christina Neser, et al.
Pageof 68

Showing results (631-640 of 676) with videos related to

Sort By:
Pageof 68
Lancet (London, England)|April 17, 2017
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 studyBrian G Feagan, William J Sandborn, Geert D'Haens, et al.
Gastroenterology|July 15, 2019
Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in MiceRocío López-Posadas, Petra Fastancz, Luz Del Carmen Martínez-Sánchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer AgentsPauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Nature Communications|March 12, 2016
Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitisMoritz Leppkes, Christian Maueröder, Sebastian Hirth, et al.
Gastroenterology|June 19, 2021
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative ColitisMaximilian Baumgartner, Michaela Lang, Hunter Holley, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Phytotherapy Research : PTR|April 27, 2026
The Allium cepa Derived Compound Propyl Propane Thiosulfonate (PTSO) Improves Tumorigenesis Due to Its Immunomodulatory Effect: A Preclinical StudyMaría Jesús Rodríguez-Sojo, Laura Hidalgo-García, Jose Alberto Molina-Tijeras, et al.
Journal of Crohn'S & Colitis|August 30, 2024
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseDominik Roth, Miriam M Düll, Ludwig J Horst, et al.
Journal of Crohn'S & Colitis|September 25, 2023
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel DiseasesSimone Weber, Selina Sitte, Anna-Lena Voegele, et al.
Biochemical Pharmacology|June 26, 2025
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposingJanine Haupt, Oliver Keminer, Christina Neser, et al.
Pageof 68